Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARMA vs UNJHA FORMUL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAFNA PHARMA UNJHA FORMUL BAFNA PHARMA/
UNJHA FORMUL
 
P/E (TTM) x 16.1 36.5 44.0% View Chart
P/BV x 2.5 3.5 71.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BAFNA PHARMA   UNJHA FORMUL
EQUITY SHARE DATA
    BAFNA PHARMA
Mar-23
UNJHA FORMUL
Mar-23
BAFNA PHARMA/
UNJHA FORMUL
5-Yr Chart
Click to enlarge
High Rs14120 705.0%   
Low Rs798 952.8%   
Sales per share (Unadj.) Rs48.829.4 166.0%  
Earnings per share (Unadj.) Rs4.80.6 758.6%  
Cash flow per share (Unadj.) Rs7.00.8 879.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.05.5 567.0%  
Shares outstanding (eoy) m23.664.48 528.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.30.5 468.0%   
Avg P/E ratio x22.922.4 102.3%  
P/CF ratio (eoy) x15.617.6 88.4%  
Price / Book Value ratio x3.52.6 137.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,59663 4,104.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1594 3,927.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,154132 876.9%  
Other income Rs m330 10,558.1%   
Total revenues Rs m1,186132 899.7%   
Gross profit Rs m1574 3,629.6%  
Depreciation Rs m531 6,927.3%   
Interest Rs m201 3,513.8%   
Profit before tax Rs m1163 3,520.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m30 591.5%   
Profit after tax Rs m1133 4,006.4%  
Gross profit margin %13.63.3 413.6%  
Effective tax rate %2.414.3 16.8%   
Net profit margin %9.82.1 457.7%  
BALANCE SHEET DATA
Current assets Rs m87323 3,771.6%   
Current liabilities Rs m46510 4,856.4%   
Net working cap to sales %35.410.3 342.8%  
Current ratio x1.92.4 77.7%  
Inventory Days Days20-  
Debtors Days Days1,302291 447.4%  
Net fixed assets Rs m42311 3,860.5%   
Share capital Rs m23745 527.9%   
"Free" reserves Rs m498-20 -2,456.7%   
Net worth Rs m73525 2,994.5%   
Long term debt Rs m840-   
Total assets Rs m1,29634 3,800.1%  
Interest coverage x6.76.7 100.2%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.93.9 23.1%   
Return on assets %10.310.0 103.4%  
Return on equity %15.411.5 134.0%  
Return on capital %16.715.8 105.6%  
Exports to sales %00-   
Imports to sales %7.90-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m91NA-   
Fx inflow Rs m88529 3,101.2%   
Fx outflow Rs m910-   
Net fx Rs m79429 2,783.7%   
CASH FLOW
From Operations Rs m50-3 -1,572.4%  
From Investments Rs m-75-1 7,346.1%  
From Financial Activity Rs m102NA-  
Net Cashflow Rs m76-4 -1,835.8%  

Share Holding

Indian Promoters % 88.4 36.9 239.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.6 63.1 18.3%  
Shareholders   7,367 4,012 183.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAFNA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAFNA PHARM. vs UNJHA FORMUL

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAFNA PHARM. vs UNJHA FORMUL Share Price Performance

Period BAFNA PHARM. UNJHA FORMUL S&P BSE HEALTHCARE
1-Day -1.28% 5.00% 1.18%
1-Month -11.90% -10.43% -0.75%
1-Year -4.38% 47.08% 61.82%
3-Year CAGR -19.10% 30.52% 18.16%
5-Year CAGR 47.52% 18.79% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAFNA PHARM. share price and the UNJHA FORMUL share price.

Moving on to shareholding structures...

The promoters of BAFNA PHARM. hold a 88.4% stake in the company. In case of UNJHA FORMUL the stake stands at 36.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAFNA PHARM. and the shareholding pattern of UNJHA FORMUL.

Finally, a word on dividends...

In the most recent financial year, BAFNA PHARM. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

UNJHA FORMUL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BAFNA PHARM., and the dividend history of UNJHA FORMUL.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.